Buying and Selling Medtech | GenomeWeb

The US life sciences sector saw a flurry of merger and acquisition activity at the end of 2013, and it may continue into early 2014, according to an analysis from PricewaterhouseCoopers.

Overall, 2013 saw a contraction of 13 percent in medtech sector M&A, with a total of 41 deals, but a surge of 15 deals worth a collective $4.77 billion in the fourth quarter "may signal a healthy turn for the industry," MassDevice reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.